This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
26 Oct 2010

ATMI LifeSciences and Austar Announce Completion of Beijing Biopharmaceutical Manufacturing Facility

ATMI, Inc. has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar.

ATMI, Inc. has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar, a Hong Kong-based comprehensive service provider to the China pharmaceutical industry. 

The joint venture, ATMI Austar LifeSciences Ltd, originated with the goal of producing and marketing high-end, ultra-clean sterile materials packaging for APIs and sterile pharmaceutical components to meet growing demand across the biopharmaceutical industry in the Asia-Pacific region. The new state-of-the-art manufacturing facility in Beijing, which was brought online today (26 October 2010) at an official Grand Opening ceremony attended by customers and Chinese FDA and government officials, represents a significant step toward that goal. 

Under the joint venture agreement, ATMI Austar LifeSciences will be producing certain ATMI LifeSciences products, including Cleansteam products, with local blow-film

Related News